Avantor® Provides First Look at Recently Completed Hydration Expansion at DCAT Week 2025
Avantor (NYSE: AVTR) has completed a major expansion at its flagship European manufacturing facility in Gliwice, Poland, significantly enhancing its hydration solutions production capabilities. The new facility quadruples the site's capacity for manufacturing, formulating, and filling USP purified water and WFI-based hydration solutions, important components in buffer preparations and cell culture media.
The expansion is part of Avantor's strategic investments in global production capacity, following recent developments at their Aurora, Ohio site and a doubled output of synthesized salts at the Phillipsburg, N.J. facility. In November 2024, the company also opened a new 60,000-square-foot Bridgewater Innovation Center in New Jersey, doubling its lab and pilot plant capacity for bioprocessing innovation.
Avantor (NYSE: AVTR) ha completato una grande espansione presso il suo stabilimento di produzione principale in Europa a Gliwice, in Polonia, migliorando significativamente le sue capacità di produzione di soluzioni idratanti. La nuova struttura quadruplica la capacità del sito per la produzione, la formulazione e il riempimento di acqua purificata USP e soluzioni idratanti a base di WFI, componenti importanti nella preparazione di tamponi e nei mezzi di coltura cellulare.
L'espansione fa parte degli investimenti strategici di Avantor nella capacità produttiva globale, a seguito di recenti sviluppi presso il loro sito di Aurora, Ohio, e di un raddoppio della produzione di sali sintetizzati presso lo stabilimento di Phillipsburg, N.J. Nel novembre 2024, l'azienda ha anche aperto un nuovo Centro di Innovazione di Bridgewater di 60.000 piedi quadrati nel New Jersey, raddoppiando la sua capacità di laboratorio e impianto pilota per l'innovazione nei bioprocessi.
Avantor (NYSE: AVTR) ha completado una importante expansión en su instalación de fabricación principal en Europa en Gliwice, Polonia, mejorando significativamente sus capacidades de producción de soluciones de hidratación. La nueva instalación cuadruplica la capacidad del sitio para fabricar, formular y llenar agua purificada USP y soluciones de hidratación a base de WFI, componentes importantes en la preparación de tampones y medios de cultivo celular.
La expansión es parte de las inversiones estratégicas de Avantor en la capacidad de producción global, tras recientes desarrollos en su sitio de Aurora, Ohio, y un aumento del doble en la producción de sales sintetizadas en la instalación de Phillipsburg, N.J. En noviembre de 2024, la empresa también inauguró un nuevo Centro de Innovación de Bridgewater de 60,000 pies cuadrados en Nueva Jersey, duplicando su capacidad de laboratorio y planta piloto para la innovación en bioprocesos.
Avantor (NYSE: AVTR)는 폴란드 글리비체에 있는 유럽 주요 제조 시설에서 대규모 확장을 완료하여 수분 공급 솔루션 생산 능력을 크게 향상시켰습니다. 새로운 시설은 USP 정제수 및 WFI 기반 수분 공급 솔루션의 제조, 조제 및 충전 용량을 사배로 늘리며, 이는 완충제 준비 및 세포 배양 매체에서 중요한 구성 요소입니다.
이번 확장은 오하이오주 아우로라의 최근 개발과 뉴저지주 필립스버그 시설에서 합성 염의 생산량을 두 배로 늘린 후 Avantor의 글로벌 생산 능력에 대한 전략적 투자 일환입니다. 2024년 11월, 이 회사는 뉴저지에 60,000 평방피트 규모의 브릿지워터 혁신 센터를 새로 개관하여 바이오프로세스 혁신을 위한 실험실 및 파일럿 플랜트 용량을 두 배로 늘렸습니다.
Avantor (NYSE: AVTR) a achevé une importante expansion de son installation de fabrication phare en Europe à Gliwice, en Pologne, améliorant considérablement ses capacités de production de solutions d'hydratation. La nouvelle installation quadruple la capacité du site pour la fabrication, la formulation et le remplissage d'eau purifiée USP et de solutions d'hydratation à base de WFI, composants importants dans les préparations de tampons et les milieux de culture cellulaire.
Cette expansion s'inscrit dans le cadre des investissements stratégiques d'Avantor dans la capacité de production mondiale, suite aux récents développements de leur site d'Aurora, dans l'Ohio, et à un doublement de la production de sels synthétisés dans l'installation de Phillipsburg, dans le New Jersey. En novembre 2024, l'entreprise a également ouvert un nouveau Centre d'Innovation de Bridgewater de 60 000 pieds carrés dans le New Jersey, doublant ainsi sa capacité de laboratoire et d'usine pilote pour l'innovation en bioprocédés.
Avantor (NYSE: AVTR) hat eine bedeutende Erweiterung seiner wichtigsten europäischen Produktionsstätte in Gliwice, Polen, abgeschlossen, wodurch die Produktionskapazitäten für Hydratationslösungen erheblich verbessert wurden. Die neue Einrichtung vervierfacht die Kapazität des Standorts zur Herstellung, Formulierung und Abfüllung von USP-reinem Wasser und WFI-basierten Hydratationslösungen, die wichtige Bestandteile bei der Pufferherstellung und in Zellkulturmedien sind.
Die Erweiterung ist Teil von Avantors strategischen Investitionen in die globale Produktionskapazität, nach jüngsten Entwicklungen an ihrem Standort in Aurora, Ohio, und einer Verdopplung der Produktion von synthetisierten Salzen in der Einrichtung in Phillipsburg, N.J. Im November 2024 eröffnete das Unternehmen zudem ein neues 60.000 Quadratfuß großes Bridgewater Innovationszentrum in New Jersey, das die Labor- und Pilotanlagenkapazität für bioprocessing-Innovationen verdoppelt.
- Quadrupled production capacity at Gliwice facility for high-purity hydration solutions
- Doubled synthesized salts output at Phillipsburg facility
- Doubled lab and pilot plant capacity with new 60,000-square-foot Innovation Center
- Strategic expansion of global manufacturing network strengthens supply chain
- None.
Facility in Gliwice,
The new production facility's advanced technologies quadruple the site's capacity for manufacturing, formulating, and filling United States Pharmacopoeia (USP) purified water and Water for Injection (WFI)-based hydration solutions. These high-purity solutions are essential in buffer preparations, cell culture media, clean-in-process (CIP), and formulation processes, supporting the stability, efficacy, and safety of biologics and other life-saving therapies.
"This latest investment strengthens our global manufacturing network, building important capacity and bringing our operations closer to customers," said Benoit Gourdier, EVP of Avantor's Bioscience Production Segment. "It ensures a dependable supply of high-quality products while strengthening our role as a trusted partner, working alongside biopharma manufacturers to produce life changing therapies."
In recent years, Avantor has made substantial investments to enhance global production capacity and introduce new products to serve the growing bioprocessing needs of drug manufacturers. This project in
In addition to increasing manufacturing capacity, Avantor has also expanded its research and innovation capabilities. In November 2024, the company opened its new 60,000-square-foot Bridgewater Innovation Center in
About Avantor
Avantor® is a leading life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. We work side-by-side with customers at every step of the scientific journey to enable breakthroughs in medicine, healthcare, and technology. Our portfolio is used in virtually every stage of the most important research, development, and production activities at more than 300,000 customer locations in 180 countries. For more information, visit avantorsciences.com and find us on LinkedIn, X (Twitter), and Facebook.
Global Media Contact
Eric Van Zanten
Head of External Communications
Avantor
610-529-6219
Eric.VanZanten@avantorsciences.com
Investor Relations Contact
Allison Hosak
Senior Vice President, Global Communications
Avantor
908-329-7281
Allison.Hosak@avantorsciences.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/avantor-provides-first-look-at-recently-completed-hydration-expansion-at-dcat-week-2025-302402531.html
SOURCE Avantor and Financial News
FAQ
What is the capacity increase at Avantor's (AVTR) Gliwice facility after the expansion?
How large is Avantor's (AVTR) new Bridgewater Innovation Center opened in November 2024?
What recent manufacturing expansions has Avantor (AVTR) completed besides the Gliwice facility?
What types of solutions will be produced at Avantor's (AVTR) expanded Gliwice facility?
